Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

exemestane

(EK-seh-MEH-stayn)
A drug used to treat postmenopausal women with advanced breast cancer or early-stage breast cancer that is estrogen receptor positive (ER+). It is used in patients whose cancer has already been treated with tamoxifen. It is also being studied in the treatment of other types of cancer. Exemestane lowers the amount of estrogen made by the body. This may stop the growth of cancer cells that need estrogen to grow. Exemestane is a type of aromatase inhibitor. Also called Aromasin.
Search NCI's Dictionary of Cancer Terms